Chemours and two other domestic manufacturers trading below $30 benefit from reshoring incentives and sector-specific catalysts.
U.S. manufacturing stocks under $30 are attracting attention as policy tailwinds, including reshoring incentives and refrigerant regulations, drive capital into domestic production. The sector contributed $2,961.4 billion to GDP in Q4 2025, reinforcing its economic impact amid favorable conditions.
Chemours, a specialty chemicals producer, reported Q1 2026 adjusted EPS of $0.05, beating consensus estimates by 225% on $1.381 billion in revenue. Shares have surged 115% year-to-date, trading at $25.26 with a forward P/E of 14 and an analyst target of $25.78.
The broader trend reflects execution catalysts from EV plant buildouts and aerospace demand, positioning select manufacturers as asymmetric opportunities despite their low valuations.